Devajit Mohajan and Haradhan Kumar Mohajan 2024. Glucagon-Like Peptide-1 Receptor Agonist (GLP-1R): An Important Therapy to Treat Type 2 Diabetes. Journal of Innovations in Medical Research. 3, 3 (Aug. 2024), 1–6.